NCT03669497: Hypo-Fractionated Radiotherapy in Breast Cancer

NCT03669497
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER++, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: Female
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must be planning for local radiation therapy
Exclusions: Patients with breast reconstruction using implants; Prior radiation to the chest wall / breast
https://ClinicalTrials.gov/show/NCT03669497

Comments are closed.

Up ↑